Dr. Robert P. Landry, MD
Nephrology (Kidney) (Nephrology Physician)
5131 Odonovan Dr Ste 100
Baton Rouge, LA 70808
Who else practices at this address →
East Baton Rouge Parish includes primary care (46% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 29
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 417
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
LA license 023736
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Our Lady of the Lake Regional Medical Center Baton Rouge, LA
- Ochsner Medical Center - Baton Rouge Baton Rouge, LA
- Baton Rouge General Medical Center Baton Rouge, LA
- St James PArish Hospital Lutcher, LA
Medical groups
- Ochsner Clinic LLC (2,864 clinicians)
- Renal Associates of Baton Rouge, LLC (26 clinicians)
- Baton Rouge Vascular Access LLC (8 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 417
- Services billed
- 2,245
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 2,990 | 30 |
| Established patient office or other outpatient visit, 30-39 minutes | 237 | 147 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 157 | 34 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 138 | 82 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 68 | 60 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 67 | 62 |
| Injection of drug or substance under skin or into muscle | 44 | 30 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 39 | 23 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 34 | 23 |
| Complete ultrasound scan behind abdominal cavity | 24 | 24 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Amlodipine Besylate Other prescribers in Baton Rouge, LA | 210 |
| Furosemide Other prescribers in Baton Rouge, LA | 148 |
| Losartan Potassium Other prescribers in Baton Rouge, LA | 103 |
| Jardiance (empagliflozin) Other prescribers in Baton Rouge, LA | 91 |
| Hydralazine Hcl Other prescribers in Baton Rouge, LA | 73 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Baton Rouge, LA | 66 |
| Spironolactone Other prescribers in Baton Rouge, LA | 57 |
| Calcitriol Other prescribers in Baton Rouge, LA | 56 |
| Lisinopril Other prescribers in Baton Rouge, LA | 46 |
| Olmesartan Medoxomil Other prescribers in Baton Rouge, LA | 44 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 45 payments worth $1,031 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $164 |
|---|---|
| Otsuka America Pharmaceutical, Inc. | $144 |
| Mallinckrodt Hospital Products Inc. | $87.92 |
| Calliditas Therapeutics US Inc. | $87.83 |
| Amgen Inc. | $80.57 |
| Bayer HealthCare Pharmaceuticals Inc. | $58.35 |
| AstraZeneca Pharmaceuticals LP | $55.19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $49.61 |
| Food and Beverage | $1,031 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.